Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis.
Vickers
Alison E M
AE
Novartis Pharmaceuticals Corporation, One Health Plaza, E. Hanover, New Jersey 07936, USA. vickers_alison@allergan.com
Saulnier
Muriel
M
Cruz
Elba
E
Merema
Marjolijn T
MT
Rose
Kristine
K
Bentley
Philip
P
Olinga
Peter
P
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D020169:Caspases / Q000378:metabolism; D003094:Collagen / Q000378:metabolism; D005109:Extracellular Matrix / Q000502:physiology / Q000648:ultrastructure; D015870:Gene Expression / Q000187:drug effects; D005819:Genetic Markers; D005978:Glutathione / Q000378:metabolism; D007150:Immunohistochemistry; D008099:Liver / Q000378:metabolism / Q000473:pathology*; D008103:Liver Cirrhosis / Q000378:metabolism / Q000473:pathology*; D008115:Liver Regeneration / Q000502:physiology; D008297:Male; D008854:Microscopy, Electron; D020411:Oligonucleotide Array Sequence Analysis; D009924:Organ Culture Techniques; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000502:physiology*
D005819:Genetic Markers; D012313:RNA; D000255:Adenosine Triphosphate; D003094:Collagen; D020169:Caspases; D005978:Glutathione